Psychosocial issues in cancer genetics: State of the art;Gendiagnostik von hereditaren tumordispositionserkrankungen: Psychosoziale aspekte

Zeitschrift fur Psychosomatische Medizin und Psychotherapie

Volumn 46, Issue 1, 2000, Pages 80-97

  Keller, Monika ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Cancer; Decision making; Ethics; Family dynamics; Genetic counseling; Genetic testing; Hereditary; Predictive testing; Psychological distress; Psychosocial

Indexed keywords

ARTICLE; CANCER GENETICS; CLINICAL PSYCHOLOGY; DISTRESS SYNDROME; ETHICS; FAMILY; GENETIC COUNSELING; GENETIC PROCEDURES; HUMAN; MEDICAL DECISION MAKING; PRACTICE GUIDELINE; RISK ASSESSMENT;

EID: 0033963857     PISSN: 14383608     EISSN: None     Source Type: Journal    
DOI: 10.13109/zptm.2000.46.1.80     Document Type: Article

References (64)

1. ASCO (1996): Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility. J Clin Oncol 14, 1730-1736.
2. Audrain, J., Rimer, B., Cella, D., Garber, J., Peshkin, B.N., Ellis, J., Schildkraut, J. (1998): Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want?J Clin Oncol 16, 133-138.
3. Bauer, A.W. (1999): Prädiktive Medizin und der Wandel ethischer Werte. Forum der DKG 14, 210-216.
4. Beckmann, M. W., Niederacher, D., Goecke, T.O., Bodden-Heidrich, R., Schnürch, H.-G., Bender, H.-G. (1997): Hochrisikofamilien mit Mamma-und Ovarialkarzinomen. Deutsches Ärzteblatt 94, 139-146.
5. Blackwood, M.A., Weber, B.L. (1998): BRCA1 and BRCA2: from molecular genetics to clinical medicine. J Clin Oncol 16, 1669-1677.
6. Bleiker, E.M.A., Aaronson, N.K., Menko, F.H., Hahn, D.E.E., van Asperen, C.J., Rutgers, E.J.T., Leschot, N.J. (1997): Genetic counseling for hereditary cancer: A pilot study on experiences of patients and family members. Patient Education and Counseling 32, 107-116.
7. Bottorff, J.L., Ratner, P.A., Johnson, J.L. (1998): Communicating cancer risk information: the challenges of uncertainty. Patient Education and Counseling 33, 67-81.
8. Bundesärztekammer (1998): Richtlinien zur Diagnostik der genetischen Disposition für Krebserkrankungen. Deutsches Ärzteblatt 95, B1120-1127.
9. Burke, W., Daly, M., Garber, J., Botkin, J., Kahn, M.J.E., Lynch, P., McTieman, A., Offit, K. (1997): Recommendations for follow-up care of individuals with an inherited predisposition to cancer. 277, 997-1003.
10. Cho, M.K., Sankar, P., Wolpe, P.R., Godmilow, L. (1999): Commercialisation of BRCA1/2 testing: practitioner awareness and use of a new genetic test. Am J Med Genet 19, 157-163.
11. Clayton, E.W. (1997): Ethical issues in presymptomatic genetic testing for cancer risks. In: Proceedings of the AARC, 35-37.
12. Codori, A.-M., Slavney, P.R., Young, C., Miglioretti, D.L., Brandt, J. (1997): Predictors of psychological adjustment to genetic testing for Huntington's disease. Health Psychol 16, 36-50.
13. Codori, A.M., Hansen, R., Brandt, J. (1994): Self-selection in predictive testing for Huntington's disease. Am J Med Genet 54, 167-173.
14. Cornelisse C.J., Devilee, P. (1997): Facts in cancer genetics. Patient Education and Counseling 32, 9-17.
15. Croyle, R.T. (1995): Psychosocial effects of screening for disease prevention and detection. New York, Oxford: Oxford University Press.
16. Croyle, R.T., Smith, K.R., Botkin, J.R., Baty, B., Nash, J. (1997):Psychological responses to BRCA 1 mutation testing: preliminary findings. Health Psychology 16 (1), 63-72.
17. Daly, M., Farmer, J., Harrop-Stein, C., Montgomery, S., Itzen, M., Costalas, J.W., Rogatko, A. (1999): Exploring family relationships in cancer risk counseling using the genogramm. Cancer Epidemiol Biomarkers Prev (April, 8), 393-398.
18. Damm, R. (1999): Gentechnik und Persönlichkeitsrechte. Forum der DKG 14, 232-241.
19. Dörmer, K. (1999): Ethik der prädiktiven Medizin in der Onkologie. Forum der DKG 14, 242-246.
20. Dudokde Wit, A.C., Duivenvoorden, H.J., van Haeringen, A., Niermeijer, M.F., Passchier, J. (1997): Psychological distress in applicants of predictive DNA testing for autosomal dominant inheritable late onset disorders. J Med Genet 34, 382-391.
21. Dudokde Wit, A.C., Tibben, A., Duivenvoorden, H.J., Niermeijer, M.F., Passchier, J., Trijsburg, R. W. (1998): Distress in individuals facing predictive DNA testing for autosomal dominant inheritable late onset disorders; comparing questionnaire results with in-depth interviews. Am J Med Genet 75, 62-74.
22. Easton, D.F., Ford, D., Bishop, D.T. (1995): Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 56, 265-271.
23. Geller, G., Bernhardt, B.A., Doksum, T., Helzlsauer, K.J., Wilcox, P., Holtzman, N.A. (1998): Decision-making about breast cancer susceptibiliy testing: how similar are the attitudes of physicians, nurse practitioners, and at-risk women? J Clin Oncol 16, 2868-2876.
24. Giardiello, F.M. (1997): Genetic testing in hereditary colorectal cancer. JAMA 278, 1278-1281.
25. Gordijn, B. (1998): Genetisierung: die wachsende Rolle der Genetik in der Gesellschaft. Public Health Forum 22, 11.
26. Harper, P. (1992): Ethical issues in genetic testing for Huntington's disease: lessons for the study of familial cancer. Disease Markers 10, 189-193.
27. Hopwood, P. (1997): Psychological issues in cancer genetics: current research and future priorities. Patient Education and Counseling 32, 19-31
28. Hopwood, P. (1998): Genetic risk counselling for breast cancer families. Eur J Cancer 34, 1477-1479.
29. Hopwood, P., Keeling, F., Long, A., Pool, C., Evans, G., Howell, A. (1998): Psychological support needs for women at high genetic risk of breast cancer. some preliminary indicators. Psycho-Oncology 7, 402-412.
30. Huggins, M., Bloch, M., Adam, S., Suchowerky, O., Trew, M. (1992): Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk. Am J Med Genet 42, 508-515.
31. Jacobsen, P.B., Valdimarsdottir, H.B., Brown, K., Offit, K. (1997): Decision-making about genetic testing among women at familial risk for breast cancer. Psychosom Med 59, 459-466.
32. Jung, C. (1995): From pedigree to genogram. medgen 7, 173-174.
33. Kadmon, M., Fischer, F., Dupon, C., Bähring, J., Leichtweis, B., Sun, M.H., Gebert, J. (1996): Nachweis Tumor-assoziierter Gene und mögliche prophylaktische Therapiestrategien bei Kolonkarzinom. Forum der DKG 11, 111-112.
34. Kash, K.M., Holland, J., Halper, M.S., Miller, D.G. (1992): Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 84, 24-30.
35. Kash, K.M., Lerman, C. (1998): Psychological, social and ethical issues in gene testing. In: Holland, J.C. (edt.): Psycho-oncology, 196-207, New York, Oxford: Oxford University Press.
36. Kessler, S. (1993): The spouse in the Huntington disease family. Family Systems Medicine 11, 191-199.
37. Kreienberg, R., Volm, T. (1999): Vorstellung des Projektes "Familiärer Brustkrebs". Forum der DKG 14 (3), 201-202.
38. Lerman, C., Biesecker, B., Benkendorf, J.L., Kermer, J., Gomez-Caminero, A., Hughes, C., Reed, M.M. (1997): Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst 89, 148-157.
39. Lerman, C., Daly, M., Sands, C., Balshem, A., Lustbader, E., Heggan, T., Goldstein, L., James, J., Engstrom, P. (1993): Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst 85, 1074-1080.
40. Lerman, C., Highers, C., Lemon, S.J., Main, D., Snyder, C., Durham, C., Narod, S., Lynch, H.T. (1998): What you don't know can hurt you: adverse psychologic effects in members of BRCA2-linked families who decline genetic testing. J Clin Oncol 16, 1650-1654.
41. Lerman, C, Hughes, C., Trock, B.J., Myers, R.E., Main, D., Bonney, A. (1999): Genetic testing in families with hereditary nonpolyposis colon cancer. JAMA 281, 1618-1622.
42. Lerman, C., Marshall, J., Andrain, J., Gomez-Caminero, A. (1996a): Genetic testing for colon cancer susceptibility: anticipated reactions of patients and challenges to providers. Int J Cancer 69, 58-61.
43. Lerman, C., Narod, S., Schulman, K., Hughes, C., Gomez-Caminero, A., Bonney, G., Gold, K., Track, B. (1996b): BRCA1 testing in families with hereditary breast-ovarian cancer - a prospective study of patient decision making and outcomes. JAMA 275, 1885-1892.
44. Lerman, C., Schwartz, M.D., Rimer, B.K., Miller, S.M., Daly, M., Sands, C: (1996c): A randomized trial of breast cancer risk counseling: interacting effects of counseling, edudational level, and coping style. Health Psychology 15, 75-83.
45. Lerman, C., Seay, J., Balshem, A., Audrain, J. (1995): Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet 57, 385-392.
46. Lyman, G.H., Kuderer, N.M. (1997): Basic population and cancer genetics and their use in the assessment of cancer risk. Eur J Cancer 33, 2160-2166.
47. Lynch, H.T., Watson, P. (1998): BRCA1, pathology and survival. J Clin Oncol 16, 395-396.
48. Marteau, T.M., Dundas, R., Axworthy, D. (1997): Long-term cognitive and emotional impact of genetic testing for cystic fibrosis: the effects of test result and gender. Health Psychol 16, 51-62.
49. M̈ller-Pozzi, H. (1985): Identifikation und Konflikt. Psyche 39, 877-904.
50. Propping, P. (1999): Der Traum vom perfekten Kind. Die Zeit, Nr 6, 4. Feb., 31.
51. Robinson, G.E., Rosen, B.P., Bradley, L.N., Rockert, W.G., Carr, M.L. (1997): Psychological impact of screening for familial ovarian cancer: reactions to initial assessment. Gynecol Oncology 65, 197-205.
52. Struewing, J.P., Hartge, P., Wacholder, S., Baker, S., Berlin, M., McAdams, M., Timmermann, M.M. (1997): The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. NEJM 336, 1401-1408.
53. Tessaro, I., Borstelmann, N., Regan, K., Rimer, B.K. (1997): Genetic testing for susceptibility to breast cancer: findings from women's focus groups. J Women's Health 6, 317-327.
54. Thomson, E.J. (1997): Ethical, legal and social issues in testing for cancer risks. In: Proceedings of the AARC, 32-34.
55. Thorlacius, S. (1998): Population-based study of risk of breast cancer in carriers of BRCA 2 mutation. Lancet 352, 1337-1339.
56. Tibben, A., Duivenvoorden, H.J., Vegter-van der Vlis, M., Niermeijer, M.F., Frets, P.G., van de Kamp, J.J.P., Roos, R.A.C. (1993): Presymptomatic DNA testing for Huntington disease: identifying the need for psychological intervention. Am J Med Gen 48, 137-144.
57. Tibben, A., Niermeijer, M.F., Roos, R.A. (1992): Understanding the low uptake of presymptomatic testing for Huntington's disease. Lancet 340, 1416.
58. Tibben, A., Timman, R., Bannink, E.C., Duivenvoorden, H.J. (1997): Threee-year follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners. Health Psychol 16, 20-35.
59. Valdimarsdottir, H.B., Bovbjerg, D.H., Kash, K.M., Holland, J.C., Osborne, M.P. Miller, D.G. (1995): Psychological distress in women with a familial risk of breast cancer. Psycho-Oncology 4, 133-141.
60. Visser, A., Bleiker, E. (1997): Introduction: genetic education and counseling. Patient Education and Counseling 32, 1-7.
61. Watson, M., Duvivier, V., Walsh, M., Ashley, S., Davidson, J. (1998): Family history of breast cancer: what do women understand and recall about their genetic risk? J Med Genet 35, 731-738.
62. Wellisch, D.K., Hoffman, A.,Gritz, E. (1995): Psychological concerns and care of daughters of breast cancer patients. In: Baider, L., Cooper, C.L., Kaplan De-Nour, A. (edts.): Cancer and the family, 289-304. Chichester, New York, Brisbane: Wiley & Sons.
63. Wellisch, D.K., Schains, W., Gritz, E.R., Wang, H. (1996): Psychological functioning of daughters of breast cancer patients. Part III: Experiences and perceptions of daughters related to mother's breast cancer. Psycho-Oncology 5, 271-281.
64. Worringen, U., Vodermaier, A., Faller, H., Dahlbender, R.W. (1999): Konzeption und erste Erfahrungen mit dem psychoonkologischen Beratungskonzept im Schwerpunktprogramm familiärer Brust-und Eierstockkrebs (in Vorbereitung).